NEQSOL Holding Acquires One of the World’s Largest Titanium Producers
16.10.2024 14:53:00 EEST | Business Wire | Press release
NEQSOL Holding, a global investment group managing diverse businesses across 11 countries from headquarters in Amsterdam, Baku, and Kyiv, is currently in the process of acquiring the United Mining and Chemical Company JSC (UMCC) – one of the largest titanium ore raw material producers in the world.
Cemin Ukraine, a company part of NEQSOL Holding, is in the process of purchasing 100% of the shares of the state-owned United Mining and Chemical Company following an auction for the company’s privatization. The privatization deal was approved by the Cabinet of Ministers of Ukraine and is now subject to further regulatory approval.
United Mining and Chemical Company JSC is among the top ten producers and processors of titanium and zirconium ore concentrates in the world. In 2020, the company recorded production of 350,000 tons of titanium and zirconium ore concentrates. UMCC was established by the government of Ukraine to manage and operate Vilnohirsk Mining and Metallurgical Plant in the Dnipropetrovsk region and Irshansk Mining and Processing Plant in the Zhytomyr region of Ukraine.
With the acquisition of the United Mining and Chemical Company, NEQSOL Holding continues to implement strategic international business expansion. UMCC is one of the world’s largest producers of titanium raw materials, which are of great importance and application in various strategic industries. Upon completion, this deal will strengthen the Holding’s position in the international business arena.
Volodymyr Lavrenchuk, Regional Director of NEQSOL Holding Ukraine, commented: “NEQSOL Holding is currently in the process of acquiring UMCC, which includes several further steps. With this bold move, the Holding is contributing to Ukraine’s rebuilding efforts and positively signaling to other global investors to consider investment in Ukraine. Upon completion, the Holding looks forward to the further strategic development and modernization of UMCC, in compliance with all global controls related to the titanium industry.”
About NEQSOL Holding:
NEQSOL Holding is a global investment group employing over 12,000 people in 11 countries, including the U.S., U.K., Azerbaijan, Ukraine, the Netherlands, Georgia and Turkey. The group operates through its three headquarters in Amsterdam, Baku, and Kyiv, managing businesses in telecommunications, energy, construction, high-tech and now titanium industries. NEQSOL Holding serves more than 25 million customers worldwide. https://www.neqsolholding.com/
About UMCC Titanium:
UMCC is a mining company in the titanium mineral sands business, with operations in the upstream segment of mineral resources extraction, processing and beneficiation. UMCC is one of the largest ilmenite and rutile miners in the world. Since 2019, it has been in the management of the State Property Fund of Ukraine. It is among the 100 largest taxpayers of Ukraine. https://www.umcc-titanium.com/en/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241016441111/en/
Contacts
Jon Chandler: Media@Tiltonconsultancy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 14:33:00 EEST | Press release
The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simultaneously building a robust pipeline of next-generation programs in AI-guided neuromodulation and min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 14:24:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: "While the median age of diagnosis for CLL is 70 and the average age of treatment initiation is 75, many pivotal trials still underrepresent the patients that physicians most often see in practice. These data show that the durable benefit of
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 14:00:00 EEST | Press release
Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction. GreensLedge Capital Markets advised the seller. About Clearlake Clearlake Capital is a leading global alternative a
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 14:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrated statistical superiority over deucravacitinib for all key secondary endpoints, including PASI 90 response and Static Physician's Global Assessment (sPGA) 0 at week 16. Zasocitinib was generally well tolerated with a consistent safety and tolerability profile and no new safety signals identified. Perspectives on head-to-head zasocitinib study “In this head-to-head study, zasocitinib clearly demonstrated
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 13:30:00 EEST | Press release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reliability, operational efficiency and sustainability performance. The partnership brings together LTTS’ expertise in forward looking technologies and extensive experience ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom